Ostomy - Nu-Hope One-Piece Post-Operative Systems

SAN DIEGO -- Statin therapy decreased the risk for developing acute cholangitis among patients with primary sclerosing cholangitis, according to research presented at Digestive Disease Week 2022. Primary sclerosing cholangitis [PSC] is a cholestatic biliary disease whose analysis and underlying biology remains fairly poorly understood, Chiraag Kulkarni, MD, internal medicine specialist at Stanford University, said. The complications of PSC are the development of acute cholecystitis, significantly elevated risk for GI malignancy and the development of cirrhosis, and ...

>Read More

SAN DIEGO -- Corticosteroid use should be minimized in patients with inflammatory bowel disease to reduce the risk for invasive fungal infections, according to research presented at Digestive Disease Week 2022. We know that the immunosuppressants used to treat IBD increase the risk for infection and multiple studies have shown that corticosteroids are by far the worst agents, Martin H. Gregory, MD, of the division of gastroenterology at Washington University School of Medicine in St. Louis, said. There hasnt been a large scale, systematic study to see what risk ...

>Read More

SAN DIEGO -- Baseline magnetic resonance index of activity score independently predicted the longer-term need for surgery, rescue corticosteroids or hospitalizations among patients with Crohns disease. Multiple methods have been developed to predict outcomes in Crohns disease. ... The magnetic resonance index of activity, or MaRIA score, is used to quantify disease severity, it has been validated against the Crohns disease endoscopic index of severity, Alvin George, MD, internal medicine resident at Washington University School of Medicine in St. Louis, said at ...

>Read More

SAN DIEGO -- Minimal long-term cardiac safety findings were reported with ozanimod treatment in patients with ulcerative colitis and relapsing multiple sclerosis, according to research presented at Digestive Disease Week 2022. Ozanimod is a newly approved, oral sphingosine-1-phosphate (S1P) receptor modulator that specifically targets S1P1 and S1P5 and prevents lymphocyte migration to the intestines. Its approved in the U.S. and in Europe for the treatment of moderately to severely active UC as well as relapsing multiple sclerosis, Millie Dascomb Long, MD, MPH, of the ...

>Read More

DENVER -- Patients with infectious keratitis who underwent penetrating keratoplasty earlier in the course of their infection had better postoperative outcomes compared with those who waited longer before having surgery, according to a study. At the ARVO meeting, Troy Teeples, MD, an ophthalmology resident at the University of Colorado, said that neither the infectious etiology itself nor age, sex or race played a role in outcomes. ...

>Read More

Waning population immunity against smallpox -- a result of discontinued vaccination campaigns for the now-eradicated disease -- has established the landscape for the resurgence of monkeypox, researchers said. They came to that conclusion after systematically reviewing dozens of studies and other documents for data on the evolution of monkeypox epidemiology over the past 50 years, which revealed that cases have been increasing since routine smallpox vaccination ceased. Their findings were published in February in PLoS Neglected Tropical Diseases, months before a growing ...

>Read More

SAN FRANCISCO -- Results presented here showed women were more likely to experience arthrofibrosis after ACL reconstruction with quadriceps tendon autograft compared with men, and larger graft size increased the risk of arthrofibrosis. Rebecca Haley, BA, and colleagues reviewed all patients who underwent ACL reconstruction with a soft-tissue quadriceps tendon autograft to identify factors that may lead to arthrofibrosis. We had arthrofibrosis as requiring a secondary procedure for lysis of adhesions within 6 months of the primary surgery due to the inability to regain terminal extension, ...

>Read More

Product Listings for Ostomy - Nu-Hope One-Piece Post-Operative Systems